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To further characterize the molecular events supporting the tumor suppressor activity of Scrib in
mammals, we aim to identify new binding partners. We isolated MCC, a recently identiﬁed binding
partner for b-catenin, as a new interacting protein for Scrib. MCC interacts with both Scrib and the
NHERF1/NHERF2/Ezrin complex in a PDZ-dependent manner. In T47D cells, MCC and Scrib proteins
colocalize at the cell membrane and reduced expression of MCC results in impaired cell migration.
By contrast to Scrib, MCC inhibits cell directed migration independently of Rac1, Cdc42 and PAK acti-
vation. Altogether, these results identify MCC as a potential scaffold protein regulating cell move-
ment and able to bind Scrib, b-catenin and NHERF1/2.
Structured summary:
MINT-7211022: SCRIB (uniprotkb:Q14160) and MCC (uniprotkb:P23508) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7210609: SCRIB (uniprotkb:Q14160) physically interacts (MI:0915) with MCC (uniprotkb:P23508)
by two hybrid (MI:0018)
MINT-7210759, MINT-7210792: SCRIB (uniprotkb:Q14160) physically interacts (MI:0914) with PIX beta
(uniprotkb:Q14155) by pull down (MI:0096)
MINT-7210883, MINT-7210820: SCRIB (uniprotkb:Q14160) physically interacts (MI:0914) with MCC (uni-
protkb:P23508) by anti bait coimmunoprecipitation (MI:0006)
MINT-7210634, MINT-7210690, MINT-7210731: SCRIB (uniprotkb:Q14160) physically interacts (MI:0914)
with MCC (uniprotkb:P23508) by pull down (MI:0096)
MINT-7211267: E6 (uniprotkb:P06463) physically interacts (MI:0915) with SCRIB (uniprotkb:Q14160),
SNX27 (uniprotkb:Q96L92), UTRN (uniprotkb:P46939), CASK (uniprotkb:O14936), DMD (uni-
protkb:P11532) and Dlg (uniprotkb:Q12959) by pull down (MI:0096)
MINT-7211237: MCC (uniprotkb:P23508) physically interacts (MI:0915) with SCRIB (uniprotkb:Q14160),
EZR (uniprotkb:P15311), SNX27 (uniprotkb:Q96L92), NHERF1 (uniprotkb:O14745) and NHERF2 (uni-
protkb:Q15599) by pull down (MI:0096)
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A number of genetic and epigenetic alterations are required for
the development of tumors, including both loss of tumor suppres-
sive mechanisms and the acquisition of tumor promoting, or onco-
genic changes. Scribble is a polarity regulator that was identiﬁed in
a Drosophila screen for mutations that promote tumor progression
in cooperation with activated Ras [1,2]. Loss of Scribble is sufﬁcientlsevier B.V. All rights reserved.
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and metastasis in combination with Ras, Raf or Notch [1,3,4].
The mammalian homologue, Scrib, is linked to oncogenic pro-
cesses and harbors several features of tumor suppressor activity,
including downregulation of its expression in human cancers
[5,6]. In particular, in high risk Human Papilloma Virus type 16
(HPV16) infected cells, Scrib expression is downregulated as a
consequence of interaction via its PDZ domains with the E6 onco-
protein, contributing to a loss of cell polarity [7,8]. Immunohisto-
chemical analysis of uterine cervical tissues reveals a concomitant
decrease of Scrib expression with progression from normal cervical
tissue to invasive cervical cancers [9]. Expression of Scrib is altered
in pathological colon epithelia samples in association with loss of
tissue architecture [10,11] and in lobular breast cancer cells where
Scrib expression is absent in a subset of carcinomas [12]. This tumor
suppressor activity was recently conﬁrmed and relies on its ability
to regulate mammary epithelial cells morphogenesis and apoptosis
induced by oncogenes through the JNK pathway as well as through
deregulation of the MAPK signalling [13,14].
Here, we identify MCC (Mutated in Colorectal Cancer), a protein
of unknown function, as a new partner for Scrib. MCC interacts
with Scrib through a PDZ-binding motif required for its membrane
localization. Moreover, MCC peptide pull-down experiments
conﬁrmed the interaction with Scrib and identiﬁed NHERF1/2 as
new MCC partners. Furthermore, we show that, like Scrib, MCC is
involved in directed cell migration.2. Materials and methods
2.1. Cell culture and cell transfection
T47D, Caco2, HeLa and MCF10-2A cells were grown in accor-
dance with ATCC recommendations. T47D cells were transfected
with siRNA using Oligofectamine reagent and nucleofected with
plasmids according to the manufacturer’s instructions (Invitrogen
and Amaxa, respectively).
2.2. Plasmids, siRNA and shRNA
The Scrib constructs have been previously described [15]. shScrib
pSUPER vectors have been described [6]. A negative shRNA control
targeting the Luciferase protein (shLuc) was added to these experi-
ments [16]. siRNA sequences: siMCC-2 (CCAGUCUACCAUGGUUACU)
siMCC-3 (GGAGGGUCAGAGAGCUUCA) and siGFP (GFP-22 from Qia-
gen). The initial MCC cDNA was obtained from the RZPD and PCR
were realized to obtain MCC WT, and MCCD3 which is mutated in
the carboxy-terminus sequence and deleted of the PDZ-binding site,
and MCC C-Ter (amino acids 489–829). The PCR products encoding
these cDNA were cloned using the GatewayTM technology.
2.3. Antibodies
Mouse anti-MCC antibody is from BD Transduction laboratories.
Goat anti-Scrib and anti-Myc antibodies are from Santa Cruz Bio-
technology. Anti-bPIX polyclonal antibody is from Chemicon Inter-
national. Anti-GFP antibody is from Roche. Secondary antibodies
coupled to horse radish peroxydase were purchased from Dako.
Alexa-conjugated antibodies for immunostaining are from Jackson
ImmunoResearch laboratories.
2.4. Protein procedures
Protein extractions, pull-down experiments, peptides competi-
tion and immunoprecipitations were performed as previously
described [15].2.5. Peptide pull-down assays and mass spectrometry analysis
Peptides corresponding to carboxy-termini of Human MCC,
MCCD3 and control peptide from HPV16 E6 were synthesized
(Eurogentec, Belgium) and cross-linked to NHS-activated Sephar-
ose 4 Fast Flow beads (GE Healthcare). Pull-down experiments
were performed using HEK 293T cell lysates and interacting pro-
teins were identiﬁed by mass spectrometry after in-gel digestion
as previously described [6].
2.6. Immunoﬂuorescence procedures
Collagene plated cells unstimulated or stimulated with 1 nM
heregulin were ﬁxed in 4% paraformaldehyde in PBS for 20 min
or in methanol at 20 C for 2 min, permeabilized in 0.1% Triton
X-100 for 5 min, and blocked with 10% fetal calf serum in PBS for
at least 30 min before antibody incubations. Scrib antibody C20
was incubated 60 min at room temperature and actin was stained
for 30 min with TRITC-labelled phalloidin (Sigma). Nuclei were
stained with Hoechst. Confocal microscopy was performed using
a Zeiss LSM 510 using 63X oil-immersion objective (Plan Achro-
matic, NA 1.3).2.7. Boyden chamber assays
Cell migration was evaluated using 8-lm pore polycarbonate
membrane Transwell chambers (Corning Costar) as previously
described [17].
2.8. MTT assays
The bottom side of plates was coated with 25 lg/ml rat-tail
collagen I (Roche). Serum starved cells were plated and incu-
bated for 16 h in medium without serum. One microgram per
milliliter MTT was added for 90 min. Cells were lysed and fol-
lowing addition of DMSO, the OD at 570 nm was read with a
spectrophotometer.
2.9. Yeast two-hybrid screens
Yeast two-hybrid screens were performed as described [18]. All
yeast media were prepared as described [18,19]. Positive clones
were sequenced. Sos recruitment-based yeast two-hybrid was
used as describred by Thalappilly et al. [18].3. Results
3.1. The carboxy-terminus of MCC interacts with the third PDZ domain
of Scrib
In an attempt to better understand the tumor suppressor func-
tions of Scrib, we undertook a yeast two-hybrid screen to identify
new partners using the entire sequence of Scrib as a bait. Two
clones of interest were isolated, one encoding bPIX, a known part-
ner of Scrib, and another encoding MCC [15]. MCC is predicted to
form coiled-coil structures, which are known to be involved in pro-
tein–protein interactions [20,21]. Transcription of the MCC gene
results in two major mRNA isoforms, encoding two proteins of
1019 and 829 amino acids, both containing a ﬁrst class carboxy-
terminus PDZ-binding motif ETSL [22]. Sequence comparison be-
tween MCC and the three MCC isoforms present in D. melanogaster
(dMCC) reveals a signiﬁcant percentage of amino acid identity (29%
within the N-terminus and 24% within the C-terminus), including
the C-terminal PDZ-binding motif.
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experiments were performed with Nus-tagged proteins fused to
Scrib or to various Scrib regions (Fig. 1A). Both endogenous MCC
isoforms (apparent molecular weight of 93 and 113 kDa, respec-
tively) extracted from MCF10-2A cells were efﬁciently precipitated
with Nus-Scrib or any construct containing the PDZ domains, but
not with constructs deleted of the PDZ domains (Fig. 1A, compare
lanes 2, 5, and 8 with lanes 3, 4, 6, 7 and 9). The PDZ domains of
Scrib are required to speciﬁcally interact with MCC since the PDZ
of Erbin (a LAP family member) does not interact (Fig. 1A, lane
10). As the different PDZ domains of Scrib have diverse binding
speciﬁcities [23], GST-tagged PDZ domains of Scrib were individu-
ally tested for interaction with MCC (Fig. 1B). Strong binding was
found with the third PDZ domain (PDZ 3) and to a lesser extent
with PDZ 1 (Fig. 1B, lanes 4 and 6). Since the same proﬁle of bind-
ing is observed when the membrane is blotted with an anti-bPIX
antibody, we wondered if MCC could compete with bPIX for bind-
ing to Scrib (Fig. 1B). To test this possibility, increasing amounts of
a 15-mer peptide mimicking the bPIX or MCC C-terminal motif
were added to cell extracts before anti-Scrib immunoprecipitation.
The bPIX peptide efﬁciently competes for the Scrib–bPIX interac-
tion as expected (Supplementary Fig. S1) [23]. In contrast, a
competition was found with the MCC peptide only at high concen-
tration (Supplementary Fig. S1). No competition was observed
when using a peptide deleted of the last three amino acids
(MCCD3). These results suggest that MCC poorly competes with
bPIX for its interaction for Scrib.
Peptide pull-down experiments were performed using the MCC
peptides as baits and lysates from HEK 293T cells (Fig. 1C). Several
PDZ domains containing proteins were speciﬁcally precipitated
with the wild-type peptide and identiﬁed by mass spectrometry,
including Scrib, Snx27 and NHERF1/2, the latest being scaffold pro-Fig. 1. The PDZ-binding motif of MCC interacts with the PDZ domains of Scrib and NH
constructs of Nus-tagged Scrib (lower panel). MCC was identiﬁed by Western blotting w
as evaluated by staining the membrane with Ponceau Red (data not shown). (B) Lysates
proteins were revealed by Western blotting. The same amount of GST fusion proteins was
of MCC WT or D3 and E6, a peptide from the HPV 16, used as positive control, were in
Speciﬁc proteins of MCCWT and E6 are in red and black, respectively. Scrib, Dlg and CASK
total lysate.teins able to form a complex with Ezrin (Fig. 1C) [24]. Interestingly,
a large-scale study of protein–protein interactions in human cells
using a mass spectrometry-based approach also identiﬁed MCC
as a partner of Ezrin, probably through interaction with NHERF1/
2 [25]. The interaction between MCC and Scrib was also detected
in coimmunoprecipitation experiments performed with different
EGFP-tagged constructs of Scrib, conﬁrming the requirement of
the PDZ domains for the interaction with a Myc-tagged MCC
(Fig. 2A, compare lanes 2 and 8 with 3 and 9, respectively). As ex-
pected, deletion of the PDZ-binding domain of MCC abolishes the
interaction (Fig. 2A, compare lanes 2 and 5). Altogether these re-
sults clearly identify MCC as a new binding partner for Scrib, and
demonstrate that this interaction occurs through the carboxy-ter-
minus of MCC and the PDZ domains of Scrib. This interaction is
conserved between mammals and ﬂies, since Drosophila MCC is
efﬁciently coimmunoprecipitated with Drosophila Scribble when
expressed together in COS-7 cells (data not shown).
3.2. Endogenous MCC and Scrib interact in epithelial cells
MCC is widely expressed in mouse tissues, and is mainly re-
stricted at the plasma membrane, with speciﬁc enrichment at the
apical or lateral borders depending on the tissues [26]. This subcel-
lular localization overlaps the localization of Scrib, which is a
membrane-associated protein [12,15,16]. To evaluate the interac-
tion between endogenous Scrib and MCC, coimmunoprecipitations
were done using two antibodies directed against Scrib (C-20 and
K-21) (Fig. 2B). MCC was coimmunoprecipitated with the two Scrib
antibodies in both mammary MCF10-2A and colonic Caco2 cell
extracts (Fig. 2B, lanes 1 to 4) whereas no interaction was observed
with a PICK-1 antibody used as control in MCF10-2A (Fig. 2B) and
in Caco2 cells (data not shown). In MCF10-2A cells both isoformsERF1/2 in vitro. (A) Lysates from epithelial MCF10-2A cells were incubated with
ith a speciﬁc anti-MCC antibody. An equal amount of recombinant protein was used
from HEK293T cells were incubated with GST fusion proteins, as indicated. Bound
evaluated by staining the membrane with Ponceau Red. (C) The 15 last amino acids
cubated with cell extracts. Bound proteins were identiﬁed by mass spectrometry.
are known as interactors of E6. Asterisk: DMD is the dystrophin Dp71b isoform. TL:
Fig. 2. MCC interacts with Scrib through its PDZ-binding motif and the PDZ domains of Scrib in vivo. (A) HEK293 T cells transfected with Scrib fused to EGFP with or without
the PDZ domains and Myc-tagged wild-type or D3 MCC were lysed and subjected to immunoprecipitation with an anti-Myc. Bound partners were then detected using anti-
GFP antibody. Myc-tagged immunoprecipitated proteins were detected with anti-Myc to control the efﬁciency of the immunoprecipitation. The EGFP alone was not detected
due to its small size in this particular experiment. Immunoprecipitations performed with an anti-GFP gave the same results (data not shown). (B) Lysates fromMCF10-2A and
Caco-2 cells were incubated with anti-Scrib and anti-Pick-1 antibodies. Immunoprecipitated proteins were then analyzed with anti-MCC and anti-Scrib by Western blotting.
(C) Lysates from MCF10-2A cells were incubated with different antibodies directed against various members of the LAP family of proteins. Bound MCC was then analyzed
with an anti-MCC antibody. Immunoprecipitated proteins were detected by Western blotting with speciﬁc antibodies (IP: immunoprecipitation).
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cipitation experiments. This interaction was also observed in the
mammary epithelial cell line T47D (data not shown). Speciﬁcity
of the interaction among the LAP protein members was evaluated
and no coimmunoprecipitation was found between MCC and Erbin
or Lano, suggesting that the interaction is speciﬁc for Scrib
(Fig. 2C).
3.3. MCC is localized at the cell periphery together with Scrib in T47D
epithelial cells
We next analyzed the subcellular localization of MCC. Since, no
antibody suitable for immunostaining was available, we tran-
siently expressed equivalent amounts of different MCC proteins
N-terminally fused with EGFP in T47D cells (Fig. 3A–C). EGFP-
MCC is present both in the cytoplasm and at the cell membrane
where it colocalizes with endogenous Scrib, best visualized by
the yellow from the merge panel (Fig. 3A, left panels) [12]. Dele-
tion of the PDZ-binding motif of MCC (EGFP-MCCD3) abrogates its
colocalization with Scrib as well as its cortical accumulation
(Fig. 3A, middle panels). Conversely, a construct where GFP is
fused with the carboxy-terminal region, including the PDZ-bind-
ing motif, of MCC (amino acids 491–829, EGFP-MCC Cter) is sufﬁ-
cient to target this construct to the plasma membrane where it
colocalizes with endogenous Scrib (Fig. 3A, right panels). Thus,
MCC is apparently recruited to the plasma membrane through
its PDZ-binding motif, in a way reminiscent of the recruitment
of bPIX by Scrib in neuroendocrine cells and in T47D cells
[15,17]. To conﬁrm the involvement of Scrib in the localization
of MCC to the plasma membrane, immunoﬂuorescence was per-formed with cells stably expressing an already described shRNA
directed against Scrib [17]. In Scrib depleted cells (labelled by
an asterisk), the plasma membrane localization of MCC is greatly
reduced, whereas in cells in which Scrib expression is not com-
pletely abolished, MCC still colocalizes with Scrib at plasma mem-
brane (Fig. 3B). In these cells, depletion of Scrib did not affect the
level of endogenous MCC (Fig. 3D). All together, these results sug-
gest that Scrib is required in the cortical localization of MCC,
although other PDZ-containing proteins, like NHERF1/2, might
also partially contribute.
3.4. MCC is required for epithelial cells to migrate in response to HRG
In mammals, Scrib regulates directed cell migration by interact-
ing with bPIX, a Rac/Cdc42 guanine nucleotide-exchange factor
(GEF) [15–17,27,28]. We thus investigated a potential role of
MCC in this process. To this aim, MCC expression in T47D cells
was reduced by two siRNA and subjected to a Boyden chamber as-
say upon Heregulin (HRG) stimulation, a known chemoattractant
for these cells [17]. Efﬁciency of the MCC knockdown was analyzed
by Western blot and quantiﬁed. Between 40% and 80% of MCC
expression was decreased compared to control cells transfected
with GFP siRNA, the low molecular weight isoform being more
resistant to siRNA targeting (Fig. 4A). In these conditions, the level
of expression of Scrib was not changed and cell viability as well as
attachment properties to the collagen were checked and both were
not signiﬁcantly compromised (Fig. 4A and data not shown). As
shown in Fig. 4B (left panel), MCC depleted cells were unable to
migrate through the collagen coated ﬁlters upon HRG stimulation
compared to control cells. When compare to cells treated with
Fig. 3. MCC colocalizes with Scrib in T47D mammary cell line. (A) T47D cells were transfected with either EGFP-MCC, EGFP-MCCD3 or EGFP-MCC C-ter (green) and
immunostained 36 h post-transfection for endogenous Scrib (red) and nuclei (blue) by Hoechst 33342. Bar, 5 lm. (B) T47D cells, in which expression Scrib was knock-downed
by shRNA, were transfected with EGFP-MCC. Bar, 5 lm. (C) The expression of EGFP fusion proteins expressed in T47D cells following transfection were analyzed by Western
blotting, as well as endogenous Scrib. (D) Western blot analysis of lysates from shLuc and shScrib T47D cells shows the levels of Scrib and MCC expression. Quantiﬁcation of
the level of the two MCC isoforms (high and low molecular weight) shows no difference in expression in the absence of Scrib.
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ble (Fig. 4B, right panel). However, it is noteworthy that EGFP-MCC,
EGFP-MCCD3 or EGFP-MCC Cter overexpression do not affect sig-
niﬁcantly cell migration suggesting that though MCC is required
it is not a limiting factor in the migration process (data not shown).
Therefore, MCC knockdown in T47D cells inhibits cell migration in-
duced by HRG, a property shared with Scrib [4,17,28]. Since Scrib
regulates cell migration through interaction with bPIX to activate
Rac1 at the leading edge of migrating cells, we investigated the
ability of MCC to interfere with this process. T47D cells depleted
or not for MCC were stimulated for 5 min with HRG, and Rac1
and Cdc42 activation was monitored. Although, unstimulated cells
devoid of MCC harbor slight increase in activated Rac1 and Cdc42
compare to control (Fig. 4C, left panel), this increase does not trig-
ger PAK phosphorylation or cell migration (Fig. 4C, right panel,
Fig. 3B) as if this Rac1/Cdc42 activities were silent. In stimulated
conditions, levels of activated Rac1 and Cdc42 are similar and trig-
ger equivalent PAK phosphorylation. These results show that MCCdepletion does not interfere with early HRG signalization, as con-
ﬁrmed by ERK phosphorylation, but also the level of phosphory-
lated PAK which is the limiting element in migration of Scrib
depleted cells [17]. Therefore, conversely to Scrib, MCC inhibits cell
directed migration independently of Rac1, Cdc42 and PAK
activation.
4. Discussion
Here, we identiﬁed a physical interaction between MCC and
Scrib, a newly described tumor suppressor [14]. This interaction
is mediated by the carboxy-terminal PDZ-binding motif of MCC
and mainly the PDZ3 domain of Scrib. In T47D breast cells, immu-
noﬂuorescence analysis reveals a membrane and cytoplasmic
localization of MCC, consistent with previous data obtained in
mouse tissues [26]. The membrane-associated staining relies
exclusively on its PDZ-binding motif and overlaps the distribution
of endogenous Scrib. In the mouse, MCC is strongly associated with
Fig. 4. MCC is required for cell directed migration of T47D mammary cells. (A) Western blot and quantiﬁcation of T47D cells transfected with siRNA directed against MCC or
GFP probed by MCC, Scrib or a-tubuline antibodies. The percentage of remaining MCC proteins compared to control siRNA is shown in the central panel. Cell viability was
evaluated using a MTT assay (right panel). (B) Migration was performed in presence or absence of HRG (left panel). (C) Depletion of MCC does not affect the activation of Rac1
and Cdc42, evaluated with a GST-CRIB pull-down, following HRG treatment, as well as phosphorylation of PAK. The expression levels of MCC and Scrib were analyzed by
Western blotting. The efﬁciency of HRG treatment was assessed by controlling the amount of phosphorylated ERK.
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cells, a staining reminiscent of the distribution of NERHF1 and
NHERF2 in this cell type [24,29]. Therefore, NHERF1 and/or
NHERF2 may also be involved in targeting MCC to the plasma
membrane since both of them are able to physically interact with
MCC. This potential interaction could explain in part the remaining
protein found at the cell membrane in Scrib depleted T47D cells.
Scrib regulates cell directed migration in different cell types by
interacting with the bPIX/GIT1 complex. We found that depletion
of MCC inhibits cell directed migration as does Scrib depletion
[4,17,28]. The molecular basis for this function of MCC are cur-
rently unknown, but unlike Scrib, activation of Rac1 and Cdc42 is
not involved.
The MCC gene was initially isolated from human chromosome
5q21 by positional cloning to identify tumor suppressor genes in-
volved in familial adenomatous polyposis (FAP) [30,31]. Further
studies identiﬁed APC as the tumor suppressor gene mutated inFAP and MCC was subsequently found to be somatically mutated
in 3–7% of colorectal cancers [30–33]. More recently, MCC pro-
moter methylation was identiﬁed in around of 50% of primary
colorectal tumors, in a distinct subset of precursor lesions and
colorectal cancers associated with the serrated colorectal cancer
pathway [34–36]. Lastly, MCC was conﬁrmed as a gene candidate
in colorectal cancer using a transposon-based genetic screen in
mice [37].
Functional studies have identiﬁed MCC as a regulator of impor-
tant cellular processes relevant for carcinogenesis such as cell cycle
regulation or the nuclear factor jB (NF-jB) pathway, as it interacts
with IkB-b [38,39]. Moreover, MCC associates with b-catenin and
inhibits canonical Wnt signalling and cellular proliferation, sug-
gesting that MCC could be a tumor suppressor [36]. Finally, we also
demonstrate an interaction between MCC and NHERF1, a known
tumor suppressor in breast cancer [40]. Interestingly, NHERF1 is
known to bind b-catenin directly, and in MEF NHERF1/ cells,
2332 C. Arnaud et al. / FEBS Letters 583 (2009) 2326–2332b-catenin binding to E-Cadherin is decreased leading to an in-
creased transcriptional activity and increased cell motility
[35,36]. Therefore, it would be interesting to test whether the
PDZ-binding motif of MCC is required to inhibit the b-catenin-
dependent transcription and to determine whether Scrib could
be involved in these phenomenons.
Altogether, these results highlight a role of MCC in regulating
cell migration, a cellular process involved in carcinogenesis and
metastasis. Further studies will be required to understand the
molecular mechanisms of this regulation with respect to the inter-
play of MCC with other major actors of oncogenesis such as b-cate-
nin, NERHF1 and Scrib, as well its implication in cellular processes
such as the NF-jB pathway.
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